Definium Therapeutics
DFTX
84 hedge funds and large institutions have $13.9M invested in Definium Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 11 closing their positions.
905% more call options, than puts
Call options by funds: $9.99M | Put options by funds: $994K
11% more capital invested
Capital invested by funds: $12.6M → $13.9M (+$1.34M)
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.28% less ownership
Funds ownership: 10.36% → 10.08% (-0.28%)
5% less funds holding
Funds holding: 88 → 84 (-4)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Top Buyers
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$550K |
| 2 |
BlackRock
New York
|
+$350K |
| 3 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
+$195K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$173K |
| 5 |
Millennium Management
New York
|
+$161K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
76
Belmont Capital
Los Angeles,
California
| $21 | – | – | – |
|
|
SIS
77
Strategic Investment Solutions
Orland Park,
Illinois
| $21 | – | – | – |
|
|
AF
78
Advisornet Financial
Minnetonka,
Minnesota
| $11 | – | – | – |
|
|
HS
79
Horan Securities
Cincinnati,
United States
| $7 | – | – | – |
|
|
S
80
SignatureFD
Atlanta,
Georgia
| $7 | – | – | – |
|
|
HNB
81
Huntington National Bank
Columbus,
Ohio
| $1 | – | – | – |
|
82
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$800K | -232,027 | Closed |
|
83
Citadel Advisors
Miami,
Florida
| – | -$51K | -14,790 | Closed |
|
|
PCM
84
Prelude Capital Management
New York
| – | -$39.3K | -12,400 | Closed |
|
|
TRCT
85
Tower Research Capital (TRC)
New York
| – | -$10K | -3,103 | Closed |
|
|
BAM
86
Belpointe Asset Management
Reno,
Nevada
| – | -$1.91K | -604 | Closed |
|
|
RF
87
Robbins Farley
Bedford,
New Hampshire
| – | -$89 | -28 | Closed |
|
|
ASN
88
Advisory Services Network
Atlanta,
Georgia
| – | -$29 | -9 | Closed |
|
|
GFWA
89
Grey Fox Wealth Advisors
Rockland,
Delaware
| – | -$19 | -6 | Closed |
|
DFTX Hedge Fund Activity: Q2 2023 in Review
84 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2023, worth a combined $13.9M — up 11% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DFTX and 8 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 13 added.
The largest buyer was Cresset Asset Management, opening a new position worth an estimated $550K. The largest seller was Alyeska Investment Group, cutting an estimated $847K.
- 84 institutional investors held Definium Therapeutics (DFTX) as of Q2 2023, down from 88 in Q1 2023.
- Funds reported $13.9M of Definium Therapeutics stock for Q2 2023, up 11% quarter-over-quarter.
- 8 funds opened new Definium Therapeutics positions in Q2 2023 and 11 closed out, a net change of -3 holders.
- The largest Definium Therapeutics buyer in Q2 2023 was Cresset Asset Management, an estimated $550K added.
- The largest Definium Therapeutics seller in Q2 2023 was Alyeska Investment Group, an estimated $847K sold.
Based on aggregated 13F filings for Q2 2023.